(Q63597593)
Statements
Imatinib for Multiple Sclerosis (MS) Relapses - a Phase II, Randomised Study (English)
0 references
1 October 2018
0 references
31 December 2020
0 references
200
0 references
18 year
0 references
55 year
0 references